Barry Ticho MD, PhD is a prominent figure in the field of biotechnology, currently serving as Chief Medical Officer at Stoke Therapeutics. Ticho holds advisory roles on the boards of Sania Therapeutics and Cardior Pharmaceuticals, and is a founder and board member of Verve Therapeutics. In a previous capacity, Ticho was the Head of Development for Cardiovascular and Metabolic Diseases at Moderna Therapeutics. Ticho's educational background includes a degree in Biology from Haverford College and medical training at Harvard Medical School.